 |
| Hydroxyapatite, abbreviated as HAP, is the most widely used crystalline phase of calcium phosphate salts. Calcium phosphate salts are the main mineral components of vertebrate bones and teeth. Among calcium phosphate salts, hydroxyapatite is the most thermodynamically stable crystalline phase in body fluids and is most similar to the mineral components of human bones and teeth. | |||||||||
1306-06-5
Boss Chemical
1306-06-5
| Hydroxyapatite Basic information | |
| Product Name: | Hydroxyapatite |
| CAS: | 1306-06-5 |
| MF: | Ca5HO13P3 |
| MW: | 502.31 |
 EINECS: | 215-145-7 |
| Mol File: | 1306-06-5.mol |
| Hydroxyapatite Chemical Properties | |
| Melting point | 1100 °C(lit.) |
| density | 3.076 g/cm3(Temp: 18 °C) |
| storage temp. | 2-8°C |
| solubility | H2O: 0.3 mg/mL, clear, colorless |
| form | solid |
| color | White |
| Water Solubility | insoluble H2O [MER06] |
| Merck | 133,500 |
| InChI | InChI=1S/2Ca.H3O4P.H2O/c;;1-5(2,3)4;/h;;(H3,1,2,3,4);1H2/q2*+2;;/p-4 |
| InChIKey | CGMRCMMOCQYHAD-UHFFFAOYSA-J |
| SMILES | [Ca+2].[Ca+2].P([O-])([O-])([O-])=O.[OH-] |
| CAS DataBase Reference | 1306-06-5(CAS DataBase Reference) |
| EPA Substance Registry System | Hydroxylapatite (Ca5(OH)(PO4)3) (1306-06-5) |
